1: Current clinical evidence that early identification and treatment of ASD results in improved long-term outcomes, 2. Update on autism screening and diagnostic tools for toddlers between 18-36 months of age (this will include the new technological device, EarliPoint, which is being implemented in the Nicklaus Children's Brain Institute Neurodevelopmental Conditions program), 3. Medical evaluation and treatment recommendations for young children diagnosed with ASD